How we Ensure High Quality Clinical Testing for all our Bioequivalence Studies
Monday, 18 April 2022

Navitas Life Sciences has proven expertise in a wide variety of Bioequivalence studies which include variation in doses, dosage forms, single and double blind, dose escalation,

Continue Reading
Celebrating World Health Day with an expert session on Corporate Nutrition and Wellness to reinforce our commitment to global well-being
Tuesday, 12 April 2022

World Health Day was celebrated recently to raise awareness about the ongoing health issues that concern people across the world.

Continue Reading
Key Insights on Maintaining Digital Resilience and Data Security
Monday, 04 April 2022

Data Security is about managing risks and about coping with evolving needs, strategizing effectively for optimal efficiency.

Continue Reading
20 Years of Industry Leading Networks: The Journey so far and the Path Beyond
Monday, 28 March 2022

Pharma and Life Sciences industry experts are showing increasing focus on our industry leading networks for the exclusive and insight rich interactions that promise to shape the future of the industry.

Continue Reading
What makes our QPPV Services Unique?
Tuesday, 22 March 2022

A Qualified Person for Pharmacovigilance (QPPV) is personally responsible, by law, for the safety of the human pharmaceutical products marketed by that company in the EU.

Continue Reading
Why Foundations’ Disease Registries are important and how they are different from Clinical trials
Tuesday, 15 March 2022

Registries are a carefully curated database of people with a specific disease, it is observational and retrospective.

Continue Reading
Identifying Gaps in Diagnosis and Management of Glaucoma for Glaucoma Awareness Week
Tuesday, 08 March 2022

World Glaucoma Week is celebrated March 6-12th 2022 to raise awareness about glaucoma and the need for early diagnosis. It is the leading cause of irreversible blindness worldwide,

Continue Reading
How Navitas Life Sciences Supports Efficient Total and Transferrin bound Iron assay for Iron Sucrose formulations
Monday, 28 February 2022

Iron has an important role in certain cellular metabolic pathways and is also vital for heme synthesis and in the transport of oxygen.

Continue Reading
6 Characteristics that Define Navitas Clinical Research’s Therapeutic and Disease Specific Foundation Registry Effort
Monday, 21 February 2022

Navitas Clinical Research, a part of Navitas Life Sciences Ltd, is a full-service CRO supporting diverse clients with the design, execution,

Continue Reading
How Navitas Life Sciences is attracting more women to pursue a career in supporting Global Public Health
Monday, 14 February 2022

As a Clinical Research Organization (CRO), Navitas Life Sciences has been taking profound steps to support better care and treatment for patients with wide ranging illnesses.

Continue Reading
Page 2 of 9